Audiology Research (Feb 2021)

Alexithymia in Patients with Ménière Disease: A Possible Role on Anxiety and Depression

  • Roberto Teggi,
  • Claudia Yvonne Finocchiaro,
  • Claudio Ruggieri,
  • Omar Gatti,
  • Federica Rosolen,
  • Mario Bussi,
  • Lucio Sarno

DOI
https://doi.org/10.3390/audiolres11010008
Journal volume & issue
Vol. 11, no. 1
pp. 63 – 72

Abstract

Read online

The aim of this paper was to investigate the role of the psychological variable of alexithymia both as a risk factor for the development of Ménière’s disease (MD) and as a component that influences the personal experience of MD and the individual quality of life. We collected data from 179 Italian patients who fulfilled criteria for definite MD. Patients filled out validated self-rating questionnaires to assess alexithymia (TAS-20), quality of life (WHOQOL-BREF), anxiety and depression (HADS), perception of stress (PSS) and coping strategies (COPE). Socio-demographic data and MD clinical features were collected using a specific rating form. Subjects affected by MD showed higher levels of alexithymia compared to general population. Among MD patients, those characterized by high levels of alexithymia revealed a significant increase in anxiety and depression, greater perceived stress, a lower quality of life in psychological health and social relationships domains and the use of less mature coping strategies in comparison with MD patients with low or absent alexithymia. Our preliminary data could help in hypothesizing a role of psychological functioning in MD development and in the adaptation to the disease. The presence of alexithymia in patients suffering from MD may constitute a risk factor for the development of anxiety and depression symptoms; greater perceived stress and for poorer psychological and relational quality of life. Therefore, our study design did not allow causal inferences and further studies are needed.

Keywords